KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Amgen (AMGN) over the last 16 years, with Q3 2025 value amounting to 0.12%.

  • Amgen's Return on Invested Capital rose 300.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.09% for FY2024, which is 200.0% down from last year.
  • Latest data reveals that Amgen reported Return on Invested Capital of 0.12% as of Q3 2025, which was up 300.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Amgen's Return on Invested Capital ranged from a high of 0.21% in Q2 2022 and a low of 0.08% during Q2 2024
  • Its 5-year average for Return on Invested Capital is 0.14%, with a median of 0.12% in 2023.
  • As far as peak fluctuations go, Amgen's Return on Invested Capital soared by 600bps in 2022, and later crashed by -1000bps in 2023.
  • Over the past 5 years, Amgen's Return on Invested Capital (Quarter) stood at 0.16% in 2021, then grew by 28bps to 0.2% in 2022, then crashed by -52bps to 0.1% in 2023, then decreased by -1bps to 0.1% in 2024, then grew by 20bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.11% for Q2 2025, and 0.1% during Q1 2025.